首页 > 抗体蛋白 > 抗体
Brilliant Violet 510™ anti-mouse CD62L Antib
产品名称:
Brilliant Violet 510™ anti-mouse CD62L Antib
产品类别:
抗体
产品编号:
104441
产品应用:
104441
[价格]
规格 价格 库存
125µL ¥ 2112 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 510? under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 510? excites at 405 nm and emits at 510 nm. The bandpass filter 510/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 510? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  2. Wilfahrt D, et al. 2021. Elife. 10:. PubMed
  3. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  4. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
  5. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  6. Liao X, et al. 2015. PLoS One. 10:118176. PubMed
  7. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  8. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  9. Sun Z, et al. 2021. eLife. 10:00. PubMed
  10. Dikiy S, et al. 2021. Immunity. 54(5):931-946.e11. PubMed
  11. Todorov H, et al. 2022. iScience. 25:104927. PubMed
  12. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  13. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  14. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  15. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  16. Crauste F, et al. 2017. Cell Syst. 0.379166667. PubMed
  17. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  18. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  19. Wang X, et al. 2021. Cell. 184:5357. PubMed
  20. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  21. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  22. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  23. Nasrallah R, et al. 2020. Nature. 583:447. PubMed
RRID
AB_2561537 (BioLegend Cat. No. 104441)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线